Disability in chronic migraine with medication overuse: Treatment effects at 3 years

Headache

Volumn 47, Issue 9, 2007, Pages 1277-1281

  Andrasik, Frank ^a   Grazzi, Licia ^b   Usai, Susanna ^b   D'Amico, Domenico ^b   Kass, Steven ^a   Bussone, Gennaro ^b  

^a UNIVERSITY OF WEST FLORIDA   (United States)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Chronic migraine with medication overuse; Disability; Medication overuse headache; MIDAS; Pharmacological treatment

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; BARBITURIC ACID DERIVATIVE; CAFFEINE; CORTICOSTEROID; DIAZEPAM; ERGOTAMINE; FLUNARIZINE; INDOMETACIN; METOCLOPRAMIDE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PIZOTIFEN; PROPRANOLOL; TRIPTAN DERIVATIVE;

ADAPTATION; ADD ON THERAPY; ADULT; ANALGESIA; ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DETERIORATION; DISABILITY; DISEASE COURSE; DRUG INDUCED HEADACHE; DRUG MISUSE; FOLLOW UP; FUNCTIONAL DISEASE; HEADACHE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MOOD DISORDER; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SCORING SYSTEM; THERAPY EFFECT; TRANSFORMED MIGRAINE; WITHDRAWAL SYNDROME;

CHRONIC DISEASE; DISABILITY EVALUATION; FOLLOW-UP STUDIES; HEADACHE DISORDERS, SECONDARY; HUMANS; MIDDLE AGED; MIGRAINE DISORDERS; PAIN MEASUREMENT;

EID: 35248868748     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.00861.x     Document Type: Article

References (14)

1. Diener HC, Limmroth V. Medication overuse headache: A worldwide problem. Lancet Neurol. 2004 3 : 475 483.
2. Grazzi L, Andrasik F. Medication-overuse headache: Description, treatment, and relapse prevention. Curr Pain Headache Rep. 2006 10 : 71 77.
3. Freitag F, Lake AL III., Lipton R, Cady R, Diamond S, Silberstein S. Inpatient treatment of headache: An evidence-based assessment. Headache. 2004 44 : 342 360.
4. Baumgartner C, Wessely P, Bingol C, Maly J, Holzner F. Long-term prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache. 1989 29 : 510 514.
5. Grazzi L, Andrasik F, D'Amico D, Usai S, Kass S, Bussone G. Disability in chronic migraine patients with medication overuse: Treatment effects at 1 year follow-up. Headache. 2004 44 : 678 683.
6. Katsarava Z, Limmroth V, Finke M, Diener HC, Fritsche G. Rate and predictors for relapses in medication overuse headache: A one year prospective study. Neurology. 2003 60 : 1682 1684.
7. Katsarava Z, Muessig M, Dzagnidze A, Fritsche G, Diener HC, Limmroth V. Medication overuse headache: Rates and predictors for relapse in a 4-year prospective study. Cephalalgia. 2005 25 : 12 15.
8. Silberstein SD. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review). Rep Qual Standards Subcommittee Am Acad Neurol. 2000 55 : 754 762.
9. Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner A, Liberman J. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology. 1999 53 : 988 994.
10. Silberstein SD, Lipton RB. Chronic daily headache. Curr Opin Neurol. 2000 13 : 277 283.
11. Andrasik F. Assessment of patients with headaches. In : Turk DC, Melzack R, eds. Handbook of Pain Assessment, 2nd edn. NY : Guilford Press 2001 : 454 474.
12. Andrasik F, Lipchik GL, McCrory DC, Wittrock DA. Outcome measurement in behavioral headache research: Headache parameters and psychosocial outcomes. Headache. 2005 45 : 429 437.
13. D'Amico D, Mosconi P, Genco S, et al. The Migraine Disability Assessment (MIDAS) questionnaire: Translation and reliability of the Italian version. Cephalalgia. 2001 21 : 947 952.
14. Grazzi L, Andrasik F, D'Amico D, et al. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: Outcome at 3 years. Headache. 2002 42 : 483 490.